Nano X Imaging Ltd Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising Losses and Strategic Expansions

Nano X Imaging Ltd reported Q2 2025 earnings with revenue growth and rising losses. The company expanded its commercial footprint in the US and Europe, established collaborations with academic institutions, and developed a mobile imaging solution. However, it reported a GAAP net loss of $14.7 million and low revenue from AI solutions. Operating expenses remain high, and the company faces challenges in achieving profitability.

Nano X Imaging Ltd (NNOX) reported its second-quarter (Q2) 2025 earnings on August 12, 2025, showcasing revenue growth and an increase in net losses. The company's commercial footprint expanded in the US and Europe, with installations in countries like Romania and Greece following the attainment of the CE mark. Collaborations with academic institutions such as Duke University and Kaiser University were also established to enhance clinical education and research. Additionally, the company is developing a mobile imaging solution to expand access to high-quality diagnostic imaging, which could create new opportunities for service delivery and revenue growth. A multi-year volume supply agreement with a leading global electronics manufacturing services provider was entered to support scalable production and reduce manufacturing costs [1].

Despite these positive developments, Nano X Imaging reported a GAAP net loss of $14.7 million for Q2 2025, an increase from the $13.6 million loss in the same period of 2024 [2]. Revenue from AI solutions remained low, with only $0.1 million reported for the quarter, accompanied by a gross loss of $2.0 million. Operating expenses remained high, with sales and marketing expenses increasing due to commercialization efforts in the US market. The company is still in the process of securing import permits and certifications for certain markets, such as Mexico, which could delay expansion efforts. Nano X Imaging faces challenges in achieving profitability, with expectations for break-even in AI solutions not anticipated until 2026 [3].

The company's revenue grew to $3.04 million in Q2 2025, compared to $2.7 million a year ago. However, the net loss increased to $14.72 million, up from $13.58 million in the same period of 2024. The basic and diluted loss per share from continuing operations remained unchanged at $0.23 per share [1].

Nano X Imaging is making steady progress towards its goal of 100 non-USAC systems installations by the end of 2025. The company is targeting 100 systems by the end of the year, with more than 20 systems currently operating and scanning patients. It has identified almost each one of them for installation and operation [2]. The company's geographical focus is on the US and EU markets, with systems ready for shipment to Romania and Greece. Expansion into Latin America is being explored, while the Far East and Africa are not immediate priorities [2].

References:
[1] https://www.marketscreener.com/news/nano-x-imaging-ltd-reports-earnings-results-for-the-second-quarter-and-six-months-ended-june-30-20-ce7c51dadb8dfe20
[2] https://finance.yahoo.com/news/nano-x-imaging-ltd-nnox-070759809.html
[3] https://seekingalpha.com/news/4483254-nano-x-imaging-q2-2025-earnings-preview